Valuation: Augmedix, Inc.

Market Cap 116M 101M 93.99M 86.29M 163M 11.09B 165M 1.11B 435M 5.52B 436M 427M 18.51B P/E 2022
-2.39x
P/E 2023 -13.4x
Enterprise Value 95.78M 83.27M 77.5M 71.16M 134M 9.14B 136M 914M 359M 4.55B 360M 352M 15.26B EV / Sales 2022
1.75x
EV / Sales 2023 5.88x
Free-Float
99.74%
Yield 2022 *
-
Yield 2023 -
3 years 0.73
Extreme 0.73
6.25
5 years 0.73
Extreme 0.73
6.25
10 years 0.73
Extreme 0.73
10
Manager TitleAgeSince
Chief Executive Officer - 02/10/2024
Director of Finance/CFO - 02/10/2024
Chief Operating Officer - 02/10/2024
Director TitleAgeSince
Director/Board Member 63 10/04/2023
Director/Board Member - 02/10/2024
Date Insider Type Main position Quantity % Market Cap.
10/2/24 A Issuer sale

Chief Financial Officer

754,058 1.5256%
10/2/24 A Issuer sale

Director

74,230 0.1502%
10/2/24 A Issuer sale

Director

93,047 0.1882%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-41.98% 116M
-1.04%-0.62%-8.05%+63.04% 81.89B
-0.25%-1.66%+1.37%+70.19% 20.44B
+1.64%+0.27%-4.89%+7.59% 15.93B
-0.90%+2.52%+2.29%+10.73% 14.13B
+0.09%+0.34%+18.22%+33.88% 12.07B
+0.93%+5.62%+18.48%+84.07% 7.7B
-1.71%-0.55%+52.55%+109.86% 6.95B
-0.45%+12.51%-20.16%-2.55% 5.96B
-0.59%+2.76%+18.37%-4.63% 5.39B
Average -0.23%+2.35%+7.82%+33.02% 17.06B
Weighted average by Cap. -0.51%+1.65%+0.17%+50.68%

Financials

2022 2023
Net sales 30.93M 26.89M 25.03M 22.98M 43.39M 2.95B 44.07M 295M 116M 1.47B 116M 114M 4.93B 44.86M 38.99M 36.29M 33.32M 62.93M 4.28B 63.9M 428M 168M 2.13B 168M 165M 7.15B
Net income -24.45M -21.25M -19.78M -18.16M -34.3M -2.33B -34.83M -233M -91.52M -1.16B -91.82M -89.8M -3.9B -19.17M -16.67M -15.51M -14.24M -26.89M -1.83B -27.31M -183M -71.76M -911M -72M -70.42M -3.06B
Net Debt -4.28M -3.72M -3.46M -3.18M -6M -408M -6.09M -40.79M -16.01M -203M -16.06M -15.71M -682M -20.37M -17.71M -16.48M -15.13M -28.58M -1.94B -29.02M -194M -76.25M -968M -76.51M -74.82M -3.25B
Logo Augmedix, Inc.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Employees
1,430
  1. Stock Market
  2. Stocks
  3. AUGX Stock